| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the billing codes used for the administration of tissue |
|
|
plasminogen activator by ambulance providers under the Medicaid and |
|
|
Medicare programs. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subchapter B, Chapter 531, Government Code, is |
|
|
amended by adding Section 531.024136 to read as follows: |
|
|
Sec. 531.024136. MEDICAID BILLING CODE FOR TISSUE |
|
|
PLASMINOGEN ACTIVATOR ADMINISTERED BY AMBULANCE PROVIDERS. The |
|
|
executive commissioner by rule shall adopt a specific procedure or |
|
|
other billing code under Medicaid for the administration of tissue |
|
|
plasminogen activator by an ambulance provider. |
|
|
SECTION 2. As soon as possible after the effective date of |
|
|
this Act, the Health and Human Services Commission shall request |
|
|
that the Centers for Medicare and Medicaid Services or other |
|
|
appropriate federal agency adopt a specific procedure or other |
|
|
billing code for the administration of tissue plasminogen activator |
|
|
by an ambulance provider under the Medicare program. |
|
|
SECTION 3. If before implementing any provision of this Act |
|
|
a state agency determines that a waiver or authorization from a |
|
|
federal agency is necessary for implementation of that provision, |
|
|
the agency affected by the provision shall request the waiver or |
|
|
authorization and may delay implementing that provision until the |
|
|
waiver or authorization is granted. |
|
|
SECTION 4. This Act takes effect September 1, 2019. |